| Q52103352 | A comparative uptake study of serotonin, dopamine, and norepinephrine by platelets of acute schizophrenic patients |
| Q41448932 | A family study of HLA antigens and other genetic markers in schizophrenia |
| Q50948273 | A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. |
| Q48825512 | A new metabolically trapped agent by brain monoamine oxidase: N-methyl labeled (14C) N-methylphenylethylamine (14C-MPEA). |
| Q53936073 | A rapid, sensitive, radiometric procedure for the determination of human blood platelet monoamine oxidase activity |
| Q39603041 | A twin study on three enzymes (DBH, COMT, MAO) of catecholamine metabolism. Correlations with MMPI. |
| Q66929439 | Activation of platelet monoamine oxidase by plasma in the human |
| Q84447369 | Allelic association between dinucleotide repeats at the monoamine oxidase loci and schizophrenia |
| Q49014721 | An overview of the genetics of psychopathology |
| Q39944094 | Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs |
| Q28397719 | Application of Neurochemical Markers for Assessing Health Effects after Developmental Methylmercury and PCB Coexposure |
| Q35089415 | Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. |
| Q35447796 | Association study of monoamine oxidase A/B genes and schizophrenia in Han Chinese |
| Q38065156 | Biochemistry of Mental Depression |
| Q39209661 | Biochemistry of the Central Nervous System and Behavior |
| Q51022735 | Biogenic amine-related enzymes and personality variations in normals |
| Q34079820 | Biological Transmethylation Involving S-Adenosylmethionine: Development of Assay Methods and Implications for Neuropsychiatry |
| Q70946338 | Biological markers and psychosis |
| Q50345609 | Blood platelets in psychopharmacological research |
| Q34333461 | Clinical variables and platelet mao in schizophrenia |
| Q41905415 | Comparison of platelet count and platelet protein methods for determination of platelet mao activity |
| Q43746897 | Correlation of erythrocyte catechol-O-methyltransferase activity between siblings |
| Q44672174 | Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis |
| Q40015874 | Determination of monoamine oxidase in rat brain by electron spin resonance techniques |
| Q41677441 | Differential diagnosis of the schizophrenias and affective disorders circa 1979 |
| Q34330243 | Dimethyltryptamine levels in blood of schizophrenic patients and control subjects |
| Q39362114 | Does phenylethylamine cause schizophrenia? |
| Q53800019 | Dopamine-beta-hydroxylase: evidence for increased activity in sympathetic neurons during psychotic states. |
| Q67051091 | Effect of oxygen on human platelet monoamine oxidase |
| Q72521053 | Effects of Neuroleptic Drugs on MAO Activity |
| Q43644237 | Electrophoresis of platelet monoamine oxidase in schizophrenia and manic-depressive illness |
| Q56047038 | Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients |
| Q36887506 | Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data |
| Q23912156 | Gestational lead exposure selectively decreases retinal dopamine amacrine cells and dopamine content in adult mice |
| Q67011680 | High risk for schizophrenia: genetic considerations |
| Q40586971 | Human Biochemical Genetics of Plasma Dopamine-β-Hydroxylase and Erythrocyte Catechol-O-Methyltransferase |
| Q33848742 | Human platelet monoamine oxidase activity in health and disease: a review |
| Q35202004 | Inheritance of low erythrocyte catechol-o-methyltransferase activity in man |
| Q66923906 | Iron deficiency anemia and increased urinary norepinephrine excretion |
| Q69813766 | Letter: Contraceptives and health |
| Q72551921 | Low platelet MAO activity in chronic schizophrenics: A long-term effect of neuroleptic treatment? |
| Q40112528 | Markers in psychoses: Studies from India |
| Q45146040 | Microarray analysis of differentially expressed genes in rat frontal cortex under chronic risperidone treatment |
| Q28315965 | Monoacylcadaverines in the blood of schizophrenic patients |
| Q39286414 | Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings |
| Q50310306 | Monoamine Oxidase Activity in Blood-Platelets From Autistic Children |
| Q68823697 | Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals |
| Q41847298 | Multiple forms of monoamine oxidase in rabbit platelets |
| Q37171284 | Neurochemistry and Child Psychiatry |
| Q34050493 | Neurochemistry and behavior in man |
| Q72540447 | Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia |
| Q40135643 | Neurotoxic action of kainic acid |
| Q35558383 | No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls |
| Q39209653 | On the Development and Utilization of Assays for Biological Transmethylation Involving S-Adenosylmethionine |
| Q61714102 | Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls |
| Q40171494 | Plasma dopamine-?-hydroxylase in childhood psychosis |
| Q72632531 | Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls |
| Q70969259 | Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic Medication |
| Q52308403 | Platelet monoamine oxidase (MAO) activity and alcoholism: is there a genuine association? |
| Q35199726 | Platelet monoamine oxidase (MAO) activity: evidence for a single major locus. |
| Q39207852 | Platelet monoamine oxidase activity in 116 normal rhesus monkeys: Relations between enzyme activity and age, sex and genetic factors |
| Q50310483 | Platelet monoamine oxidase activity in children and adolescents |
| Q39701939 | Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients |
| Q71991332 | Platelet monoamine oxidase activity: relation to genetic load of schizophrenia |
| Q39900748 | Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project |
| Q67572295 | Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients |
| Q45129249 | Pre- and post-partum plasma amine oxidase differences in the rhesus monkey (Macaca mulatta). |
| Q39076865 | Reduction of Blood Platelet Monoamine Oxidase Activity in Schizophrenic Patients on Phenothiazines |
| Q66907415 | Relationships between platelet and plasma monoamine oxidase, plasma dopamine-B-hydroxylase, and urinary 3-methoxy-4-hydroxy phenylglycol |
| Q53667822 | Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. |
| Q39523491 | Schizophrenia in a North Swedish geographical isolate, 1900-1977. Epidemiology, genetics and biochemistry |
| Q40151501 | Schizophrenia: Some Current Neurochemical Approaches |
| Q39096979 | Serum creatine phosphokinase (CPK) activity in monozygotic twins discordant for schizophrenia: Heritability of serum CPK activity |
| Q39163610 | Some properties of particle-bound monoamine oxidase from human whole blood |
| Q28331143 | Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia |
| Q40806534 | Suicide attempts, platelet monoamine oxidase and the average evoked response |
| Q39810723 | The Plasma Cholinesterase Variants in Mentally Ill Patients |
| Q40179682 | The activity of tissue enzymes in iron-deficient rat and man: An overview |
| Q30598135 | The inheritance of affective disorders: A review of data and of hypotheses |
| Q70159527 | The lung as a metabolic organ |
| Q40576767 | The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system |
| Q33862039 | Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis |